Cannabinoid Stability Reviews Must Keep Blood, Plasma and Alternative Specimens Separate

A 2022 stability review surveyed cannabis-related compounds across conventional and alternative specimens. Its scope illustrates why evidence about storage in one matrix cannot automatically establish stability in another.

A stability claim needs a defined system

The review included blood and plasma, urine and oral fluid, as well as less common specimens such as bile, sweat, cerumen and dried blood spots. The analyte, container, storage conditions and measurement interval belong to the claim. Naming a temperature alone is not a complete stability protocol.

Sample change differs from human elimination

A change occurring after collection is an analytical specimen issue. Elimination from a living person is a biological exposure process. A storage finding cannot be substituted for a human half-life, and a human elimination study cannot establish that an archived sample remained chemically unchanged.

Natural and synthetic compounds require identification

The review considered multiple cannabis-related compounds. They should not be treated as sharing one proven storage profile. A conclusion needs support for the particular analyte and matrix, especially when comparing results obtained at different times or by different procedures.

Interpreting the evidence

For a stored specimen, ask what evidence matches its actual handling history. The review supplies a literature map, not a universal correction factor for every delayed analysis. It does not justify estimating an original concentration from a later result without a relevant validated relationship.

Related reading: interpreting cannabis tolerance claims.

Research reference

Elias Djilali; Lucia Pappalardo; Anna Maria Posadino; Roberta Giordo; Gianfranco Pintus (2022). Effects of the Storage Conditions on the Stability of Natural and Synthetic Cannabis in Biological Matrices for Forensic Toxicology Analysis: An Update from the Literature. Metabolites. doi:10.3390/metabo12090801.

This discussion draws on the abstract and introductory material in the supplied research synthesis.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

APD371 Maintained a Pain-Response Effect for Five Days in a Preclinical Development Study

A 2017 drug-discovery report described APD371, a selective CB2 agonist, maintaining its effect during a five-day rat osteoarthritis-pain protocol. That short preclinical finding is different from established long-term clinical efficacy. The report concerned selection of a development candidate The authors considered receptor efficacy, pharmacokinetics and pharmaceutical properties alongside an oral…

Spread the love

Read Article: APD371 Maintained a Pain-Response Effect for Five Days in a Preclinical Development Study

Two Biased CB2 Agonists Had Different Durability in a Rat Osteoarthritis Experiment

A 2021 rat study found sustained pain-response effects with JWH133 while another CB2 agonist lost efficacy after two days under its repeated-treatment protocol. Shared receptor targeting did not establish equal durability. The compounds were compared in a defined model The experiment used chemically induced osteoarthritis and measured pressure responses and…

Spread the love

Read Article: Two Biased CB2 Agonists Had Different Durability in a Rat Osteoarthritis Experiment

An Acute Cannabis Review Treated Neurocognitive Response as a Multi-Factor Question

A 2021 review argued that acute neurocognitive responses to cannabis vary with biological, pharmacological and exposure-related factors. A product label or use-frequency category alone cannot capture all the determinants discussed. The review considered interacting sources of variation It discussed brain-network activity, formulation, use frequency and differences between therapeutic and recreational…

Spread the love

Read Article: An Acute Cannabis Review Treated Neurocognitive Response as a Multi-Factor Question

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us